Virtual reality offers a new way to breathe easier for lung disease patients

NCT ID NCT07628725

Not yet recruiting Symptom relief Sponsor: University of Manitoba Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a virtual reality (VR) program that guides slow, controlled breathing and arm exercises can help people with interstitial lung disease (ILD) manage symptoms like breathlessness and fatigue. Participants will either use a VR headset or follow printed instructions at home. The study will measure changes in breathing, fatigue, exercise ability, and quality of life to see if the VR approach is practical and helpful.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Virtual reality-assisted breathing exercises
What this could lead to: If effective, this VR program could offer a new, engaging way to help people with ILD manage breathlessness and improve daily function at home.
What could go wrong: This is a small, early feasibility study with only 32 participants. It is designed to test usability, not yet to prove the treatment works. Some people may find VR uncomfortable or difficult to use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTERSTITIAL LUNG DISEASE (ILD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

interstitial lung disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INTERSTITIAL LUNG DISEASE (ILD)

More trials for these conditions

Other studies related to the condition(s) this trial covers.